Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReabold Resources Regulatory News (RBD)

Share Price Information for Reabold Resources (RBD)

Share Price is delayed by 15 minutes
Get Live Data
83.50    -0.50 (-0.60%)
Bid:
82.00
Ask:
85.00
Spread: 3.00 (3.659%)
Market Cap: £12.11m
RBD Live PriceLast checked at - London Stock Exchange

Intraday Reabold Resources Share Chart

Acquisition

6 Feb 2007 07:00

Adventis Group PLC06 February 2007 For release at 07.00 Feb 6th 2007 ADVENTIS GROUP PLC ACQUISITION OF LEAPFROG MEDICAL COMMUNICATIONS LTD Adventis Group plc ( "Adventis" or the "Company", ticker ATG), the specialistmultimedia and marketing group, is pleased to announce that it has acquiredLeapFrog Medical Communications Limited ("LeapFrog"), a leading medicaleducation company, for a total maximum consideration of £2.65 million. The total consideration will be satisfied by the payment of initialconsideration of £1.306 million, payable as to £0.874 million in cash and £0.432million by the issue of 975,169 new ordinary shares in Adventis ("New OrdinaryShares"), and by deferred consideration of £0.72 million payable in tranches of£0.24 million on each of the first, second and third anniversaries of theacquisition. Each deferred consideration tranche will be satisfied as to 60 percent in cash and as to 40 per cent payable in new ordinary shares in Adventis.There is further deferred consideration payable of up to £0.624 million, basedon the achievement of certain profit growth related criteria over the followingthree years to be satisfied annually according to performance as to 50 per centin cash and 50 per cent payable in new ordinary shares in Adventis. LeapFrog, whose clients include, GSK, Pfizer, MSD, Roche and Novartis, wasestablished in 2001. It provides a range of medical education programmes to thehealthcare industry, promotional aids for sales representatives and alsoinitiates PR campaigns aimed at healthcare professionals and consumers forimproving clients' product brand awareness. For the year ended 30 November 2006,LeapFrog reported audited turnover of approximately £1.57 million and pre-taxprofit of approximately £0.39 million. Net assets at that date amounted toapproximately £0.25 million. Tim Schofield and Gail Rowe, LeapFrog's principaldirectors, will remain with the company following the acquisition. The acquisition will create one of the industry's top three pharmaceuticalindustry service providers, becoming part of an enlarged Healthcare servicesdivision embracing Affiniti Advertising, acquired in 2005, and RoundhouseHealthAd, acquired in 2006. The addition of LeapFrog to Affiniti and Roundhouse creates a formidable,award-winning team in the Adventis Healthcare division, with over 50 employeesworking in centralised premises in the Thames Valley. The enlarged Healthcareservices operations, whose other clients include Boehringer Ingelheim, Allergan,Baxter and Merck Serono, will have the capability to provide a complete range ofintegrated marketing services, from medical education, to advertising to newmedia. It will also provide the opportunity for an increased level ofcross-selling and the ability to provide multinational clients with a greaterlocal understanding of target markets service. Application has been made for the admission to AIM of the New Ordinary Shares,which will rank pari passu with the Company's existing issued ordinary shares,and dealings are expected to commence on 9th February 2007. Charles Phillpot, CEO, Adventis Group, said: "We will now be one of the fewcompanies in the industry to offer a full service marketing capability and theability to handle larger and more complex campaigns for clients. We are nowamong the top three players in two of our three chosen market sectors." Tim Schofield and Gail Rowe said: "We see joining forces with the two topcreative agencies in our industry as a unique way of adding value to ourclients. Being able to address their various needs within one group will be atremendous bonus for us all." ENDS Enquiries: Adventis Group Plc Charles Phillpot, CEO 020 7034 4750 Peter Linnell, Finance Director & Company Secretary 020 7034 4795 Adventis Financial PR Chris Steele 020 7034 4759 Peter Binns 020 7034 4760 Editor's Note: Adventis Group plc, provides a complete range of communications services,including corporate identity programmes, advertising campaigns, media andplanning and buying, literature, public relations, packaging, exhibitions,research and planning, interiors signage and digital media. The group employs145 staff in London and the southeast. Adventis has two other divisions focusing on providing a range of services tothe property and financial sectors. Adventis Group was admitted to AIM in 2004,mainly operating as a media and marketing services provider to the propertysector. LeapFrog becomes the group's ninth operating company. www.adventis.co.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
24th Jun 20262:44 pmRNSForm 8.3 - Reabold Resources plc
24th Jun 202612:47 pmRNSForm 8.3 - Reabold Resources PLC
19th Jun 20269:39 amRNSForm 8.5 (EPT/NON-RI)
18th Jun 20269:42 amRNSForm 8.5 (EPT/NON-RI)
17th Jun 202610:18 amRNSForm 8.5 (EPT/NON-RI)
16th Jun 20265:41 pmPRNForm 8.3 - Reabold Resources Plc
16th Jun 20262:32 pmEQSForm 8.3 - REABOLD RESOURCES PLC : Opening Position Disclosure
16th Jun 20269:18 amRNSForm 8.5 (EPT/NON-RI)
15th Jun 20269:21 amRNSStatement re Possible Offer
15th Jun 20267:45 amRNSDisclosure Table
4th Jun 202611:26 amRNSStandard form for notification of major holdings
3rd Jun 20267:07 amRNSExclusivity Agreement with Zenith Energy
27th May 202612:09 pmRNSDirector/PDMR Shareholding
15th May 202612:25 pmRNSStandard form for notification of major holdings
14th May 20267:00 amRNSIssue of Equity and Total Voting Rights
7th May 20262:42 pmRNSShare Consolidation Effective
1st May 202610:15 amRNSDirector/PDMR Shareholding
27th Apr 20263:57 pmRNSResults of General Meeting & TVR
23rd Apr 20266:03 pmRNSDirector/PDMR Shareholding
20th Apr 20267:00 amRNSClarification of media article
10th Apr 20269:11 amRNSPosting of Circular and Notice of General Meeting
1st Apr 20264:41 pmRNSProposed Placing to raise £1.1 million
13th Mar 20267:00 amRNSFunding from Group of Strategic Investors
13th Mar 20267:00 amRNSFunding from Group of Strategic Investors
9th Mar 20267:00 amRNSBeacon Acquisition and Commencement of Trading
18th Feb 20267:06 amRNSPublication of Beacon Admission Document
16th Feb 202611:30 amRNSWest Newton Update
5th Feb 20267:18 amRNSReabold Notes Beacon Announcement
13th Jan 202611:53 amRNSStandard form for notification of major holdings
12th Jan 20267:00 amRNSStandard form for notification of major holdings
8th Jan 20267:00 amRNSPublication of Favourable Formal Decree
24th Dec 20257:00 amRNSStandard form for notification of major holdings
14th Nov 20257:00 amRNS-RReabold launches new interactive investor hub
24th Oct 20257:00 amRNSDanube - Parta Licence Update
10th Oct 20257:00 amRNSFurther Investment into LNEnergy
7th Oct 20257:56 amRNS€16 Million Earn Out Agreed for Colle Santo
30th Sep 20257:00 amRNSUnaudited Interim Results
26th Aug 20257:00 amRNSKey Regulatory Milestone Achieved for Colle Santo
7th Aug 20257:00 amRNSOperations Update on West Newton
11th Jul 20251:11 pmRNSResults of Annual General Meeting
16th Jun 202512:31 pmRNSDirector/PDMR Dealings
13th Jun 20254:02 pmRNSPublication of Annual Report and Notice of AGM
13th Jun 202511:57 amRNSDeferred Annual Bonus Plan 2024 Share Option Award
11th Jun 20257:00 amRNSFY Results for the year ended 31 December 2024
8th May 20257:24 amRNSConversion of Loan Notes
26th Mar 20257:00 amRNSUpdate on Colle Santo, Italy
17th Mar 20257:00 amRNSAppointment of NED to the Board of Rathlin Energy
4th Mar 202510:10 amRNSHolding(s) in Company
4th Mar 202510:09 amRNSHolding(s) in Company
31st Jan 20257:00 amRNSCompletion of Further Investment in Rathlin Energy

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.